Log In
BCIQ
Print this Print this
 

M7583

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionSelective and irreversible inhibitor of Bruton's tyrosine kinase (Btk)
Molecular Target Bruton's tyrosine kinase (Btk)
Mechanism of ActionBruton's tyrosine kinase (Btk) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/11/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today